Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nock

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugsTheodosia Maina, Berthold A Nock, Hanwen Zhang, et al.
EJNMMI Radiopharmacy and Chemistry|July 31, 2025
RM2 and DB15 analogues bearing [<sup>177</sup>Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative studyPanagiotis Kanellopoulos, Athanasios Bitzios, Ivan Zelepukin, et al.
EJNMMI Research|February 18, 2016
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translationAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
Molecules (Basel, Switzerland)|March 16, 2019
Comparing Gly<sup>11</sup>/dAla<sup>11</sup>-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the <sup>111</sup>In-SB3/<sup>111</sup>In-SB4 Radiotracer PairEmmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, et al.
Nuclear Medicine and Biology|August 25, 2015
In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin (111)In-radioligandsAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
EJNMMI Radiopharmacy and Chemistry|February 17, 2024
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncologyPanagiotis Kanellopoulos, Adam Mattsson, Ayman Abouzayed, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 12, 2024
Combination of the amide-to-triazole substitution strategy with alternative structural modifications for the metabolic stabilization of tumor-targeting, radiolabeled peptidesXabier Guarrochena, Maximilian Anderla, Philipp Salomon, et al.
Physical Review Letters|August 6, 2013
Distribution of scattering matrix elements in quantum chaotic scatteringS Kumar, A Nock, H-J Sommers, et al.
Molecular Pharmaceutics|August 19, 2016
Improved Quantification of the Beta Cell Mass after Pancreas Visualization with <sup>99m</sup>Tc-demobesin-4 and Beta Cell Imaging with <sup>111</sup>In-exendin-3 in RodentsInge van der Kroon, Lieke Joosten, Berthold A Nock, et al.
Pharmaceutics|December 1, 2020
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [<sup>99m</sup>Tc]Tc-DB4 and [<sup>111</sup>In]In-SG4 in Mice Treated with EntrestoPanagiotis Kanellopoulos, Aikaterini Kaloudi, Maritina Rouchota, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 6, 2005
Species differences of bombesin analog interactions with GRP-R define the choice of animal models in the development of GRP-R-targeting drugsTheodosia Maina, Berthold A Nock, Hanwen Zhang, et al.
EJNMMI Radiopharmacy and Chemistry|July 31, 2025
RM2 and DB15 analogues bearing [<sup>177</sup>Lu]Lu-DOTAGA via different linkers, as radiotherapeutics: a head-to-head comparative studyPanagiotis Kanellopoulos, Athanasios Bitzios, Ivan Zelepukin, et al.
EJNMMI Research|February 18, 2016
Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translationAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
Molecules (Basel, Switzerland)|March 16, 2019
Comparing Gly<sup>11</sup>/dAla<sup>11</sup>-Replacement vs. the in-Situ Neprilysin-Inhibition Approach on the Tumor-targeting Efficacy of the <sup>111</sup>In-SB3/<sup>111</sup>In-SB4 Radiotracer PairEmmanouil Lymperis, Aikaterini Kaloudi, Panagiotis Kanellopoulos, et al.
Nuclear Medicine and Biology|August 25, 2015
In vivo inhibition of neutral endopeptidase enhances the diagnostic potential of truncated gastrin (111)In-radioligandsAikaterini Kaloudi, Berthold A Nock, Emmanouil Lymperis, et al.
EJNMMI Radiopharmacy and Chemistry|February 17, 2024
Preclinical evaluation of new GRPR-antagonists with improved metabolic stability for radiotheranostic use in oncologyPanagiotis Kanellopoulos, Adam Mattsson, Ayman Abouzayed, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|September 12, 2024
Combination of the amide-to-triazole substitution strategy with alternative structural modifications for the metabolic stabilization of tumor-targeting, radiolabeled peptidesXabier Guarrochena, Maximilian Anderla, Philipp Salomon, et al.
Physical Review Letters|August 6, 2013
Distribution of scattering matrix elements in quantum chaotic scatteringS Kumar, A Nock, H-J Sommers, et al.
Molecular Pharmaceutics|August 19, 2016
Improved Quantification of the Beta Cell Mass after Pancreas Visualization with <sup>99m</sup>Tc-demobesin-4 and Beta Cell Imaging with <sup>111</sup>In-exendin-3 in RodentsInge van der Kroon, Lieke Joosten, Berthold A Nock, et al.
Pharmaceutics|December 1, 2020
One Step Closer to Clinical Translation: Enhanced Tumor Targeting of [<sup>99m</sup>Tc]Tc-DB4 and [<sup>111</sup>In]In-SG4 in Mice Treated with EntrestoPanagiotis Kanellopoulos, Aikaterini Kaloudi, Maritina Rouchota, et al.
Pageof 12